Shanxi Zhendong Pharmaceutical Financial Flexibility Index
Shanxi Zhendong Pharmaceutical financial flexibility index. Shanxi Zhendong Pharmaceutical (300158) has a Financial Flexibility Index of -0.17x as of September 2025. Free cash flow of CN¥-146.66 Million (operating CF CN¥-197.94 Million minus capex CN¥51.28 Million) represents 0% of total liabilities (CN¥882.65 Million). See 300158 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Shanxi Zhendong Pharmaceutical (2007–2024)
Financial flexibility index of Shanxi Zhendong Pharmaceutical from 2007 to 2024. Historical Financial Flexibility Index trend for Shanxi Zhendong Pharmaceutical across 18 annual periods. Check earnings quality score of Shanxi Zhendong Pharmaceutical to evaluate the quality of earnings relative to operating cash generation.
Shanxi Zhendong Pharmaceutical Financial Flexibility Index by Year (2007–2024)
Shanxi Zhendong Pharmaceutical financial flexibility index by year from 2007 to 2024. Year-by-year free cash flow to debt coverage for Shanxi Zhendong Pharmaceutical. For the full cash flow conversion analysis, see how efficiently does Shanxi Zhendong Pharmaceutical generate cash.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.11x | CN¥148.65 Million | CN¥-149.82 Million | CN¥1.32 Billion | ▲ +258.0% |
| 2023 | -0.07x | CN¥-73.74 Million | CN¥-189.95 Million | CN¥1.04 Billion | ▼ -140.7% |
| 2022 | 0.17x | CN¥232.12 Million | CN¥86.31 Million | CN¥1.33 Billion | ▼ -18.3% |
| 2021 | 0.21x | CN¥436.11 Million | CN¥284.45 Million | CN¥2.04 Billion | ▲ +3.8% |
| 2020 | 0.21x | CN¥405.90 Million | CN¥221.94 Million | CN¥1.97 Billion | ▲ +47.6% |
| 2019 | 0.14x | CN¥205.72 Million | CN¥186.35 Million | CN¥1.47 Billion | ▲ +44.7% |
| 2018 | 0.10x | CN¥178.40 Million | CN¥154.48 Million | CN¥1.85 Billion | ▲ +113.1% |
| 2017 | 0.05x | CN¥93.02 Million | CN¥45.09 Million | CN¥2.06 Billion | ▼ -28.9% |
| 2016 | 0.06x | CN¥102.09 Million | CN¥-44.72 Million | CN¥1.60 Billion | ▼ -34.6% |
| 2015 | 0.10x | CN¥198.76 Million | CN¥151.84 Million | CN¥2.04 Billion | ▼ -60.2% |
| 2014 | 0.24x | CN¥217.38 Million | CN¥73.23 Million | CN¥888.23 Million | ▲ +28.0% |
| 2013 | 0.19x | CN¥160.32 Million | CN¥-75.04 Million | CN¥838.64 Million | ▼ -75.7% |
| 2012 | 0.79x | CN¥538.15 Million | CN¥189.40 Million | CN¥684.26 Million | ▲ +21.0% |
| 2011 | 0.65x | CN¥258.31 Million | CN¥-88.73 Million | CN¥397.40 Million | ▲ +124.8% |
| 2010 | 0.29x | CN¥112.49 Million | CN¥32.40 Million | CN¥389.13 Million | ▲ +16.8% |
| 2009 | 0.25x | CN¥70.29 Million | CN¥42.28 Million | CN¥283.87 Million | ▼ -8.9% |
| 2008 | 0.27x | CN¥62.53 Million | CN¥33.18 Million | CN¥229.98 Million | ▼ -53.8% |
| 2007 | 0.59x | CN¥170.72 Million | CN¥128.65 Million | CN¥290.28 Million | — |